Sign inJoin waitlistJoin the waitlist

Aimee Hersh

Division Chief · Univ of Utah Sch of Med

Credentials: · · · ·

History

Univ of Utah Sch of Med
Present
Univ of Utah Sch of Med · Huntsman Cancer Institute & Hospital
Present

Rheumatology
University of California-San Francisco
2005–2007
Pediatrics
University of California-San Francisco
2002–2005
Alpert Medical School
1998–2002
Dartmouth College

Research

Differences in long-term disease activity and treatment of adult patients with childhood- and adult-onset systemic lupus erythematosus
Arthritis & Rheumatism · 2009 · First of 9 authors · Corresponding · 174 citations
Consensus treatment plans for induction therapy of newly diagnosed proliferative lupus nephritis in juvenile systemic lupus erythematosus
Arthritis Care & Research · 2012 · 142 citations
Childhood-onset disease as a predictor of mortality in an adult cohort of patients with systemic lupus erythematosus
Arthritis Care & Research · 2010 · First of 8 authors · Corresponding · 128 citations

Emily von Scheven
12 papers
Erica Lawson
11 papers · 4 as a fellow
Jinoos Yazdany
11 papers · 2 as a fellow
Sampath Prahalad
9 papers
JB
John Bohnsack
8 papers
Eyal Muscal
7 papers
Hermine Brunner
7 papers
Marisa Klein-Gitelman
7 papers
Dawn Wahezi
6 papers · 4 as a fellow
DM
Deborah McCurdy
6 papers
Lindsey Criswell
6 papers
Suzanne Li
6 papers

Grants

DP22-002 Epidemiology of Lupus: Longitudinal Studies in Population-Based Cohorts - 2022
NCCDPHP · U01
Contact PI · $3.6M · Utah State Higher Education System--University of Utah
2022–2027
Component B: Improving Pediatric Lupus Care and Outcomes Through the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Lupus Registry
NCCDPHP · U01
Contact PI · $2.4M · Utah State Higher Education System--University of Utah
2019–2022
Adult Outcomes of Juvenile Idiopathic Arthritis
National Institute of Arthritis and Musculoskeletal and Skin Diseases · K23
Contact PI · $817K · Utah State Higher Education System--University of Utah
2014–2019

Clinical trials

A Phase II Trial to Evaluate the Clinical Efficacy, Safety and Tolerability of MAS825 in Pediatric and Adult Participants With Still's Disease
Site PI · Recruiting · Phase 2
Novartis Pharmaceuticals
2025–2028
The Pediatric Lupus Nephritis Mycophenolate Mofetil (PLUMM) Study
Site PI · Recruiting · Phase 2
Children's Hospital Medical Center, Cincinnati
2024–2027
RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
Site PI · Recruiting · Phase 2, Phase 3
Cabaletta Bio
2023–2028
Pediatric Vasculitis Initiative
Site PI · Unknown
University of British Columbia
2013–2025